Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...
Bird flu isn’t part of the “quad-demic” of viruses circulating through the country this winter—COVID, seasonal flu, ...
The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.
The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.
Moderna has been testing an mRNA candidate for influenza viruses like the H5 and H7 strains that are seen as pandemic threats ...
The government wants Moderna to push forward with various bird flu vaccines as well as mRNA shots for other influenza strains ...
The Department of Health and Human Services has granted millions of dollars to Moderna to speed up bird flu vaccine development.
The Department of Health and Human Services (HHS) will award roughly $590 million to Moderna to accelerate the development of ...
The U.S. Department of Health and Human Services announced it will award $590 million to Moderna to accelerate the ...
To that end, HHS has granted Moderna $590 million to help accelerate the development of a bird flu vaccine. The agency announced its backing of the Massachusetts-based pharmaceutical firm about 72 ...
Moderna’s vaccine is designed to target H5 and H7 avian influenza viruses. The company plans to move into phase 3 clinical trials to test the vaccine in a larger group of people after receiving ...